How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration

Overview of attention for article published in Orphanet Journal of Rare Diseases, June 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 24,333 followers.

RT @ojrarediseases: Lack of options spurs a patient advocacy group to create its own draft guidance docs for the FDA. https://t.co/VeUBZtBr…

Lack of options spurs a patient advocacy group to create its own draft guidance docs for the FDA. https://t.co/VeUBZtBrH6 #raredisease #OJRD

Patient-Focused Drug Development: A How-To Guide -- http://t.co/j1AgdADPLb

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 7 additional X posts.